Piper Jaffray
Piper Jaffray is a client-focused, middle market investment bank and institutional securities firm founded in 1895 and based in Minneapolis, Minnesota.
Its Investment Banking activities include raising capital through equity and debt financings for corporate clients; providing financial advisory services relating to mergers and acquisitions to consumer, financial institutions, health care, technology, alternative energy, business services, and industrial growth sectors; underwriting debt issuances for government and non-profit clients; and providing financial advisory and interest rate risk management services.
The company's equity and fixed income institutional sales and trading activities include equity and fixed income advisory and trade execution services for public and private corporations, public entities, non-profit clients, and institutional investors.
View Older Stories View More Recent Stories
-
Analysts Offer Mixed Picture of Disney's (DIS) Q3 Results
-
Analysts Cheer Green Mountain's (GMCR) Move to Partner with Lavazza
-
Piper Jaffray Reviews Disney's (DIS) Q3 Results: Studio Entertainment and Media Networks Performance Drive Solid Results
-
Piper Jaffray Cuts Estimates & PT on Alpha and Omega (AOSL); Margin Expansion Not Playing Out As Expected
-
Piper Jaffray Maintains a 'Neutral' Rating on Myriad Genetics (MYGN); Q4 Tops Expectations, Guidance Mixed
-
Piper Jaffray Reiterates an 'Overweight' Rating on Cerner (CERN) After Meeting with Management
-
Piper Jaffray Maintains an 'Overweight' on Baxter (BAX); Shares Very Attractive at Current Levels
-
Piper Jaffray Reiterates an 'Overweight' Rating on Financial Engines (FNGN); Solid Qtr In Tough Market
-
Piper Jaffray Reiterates an 'Overweight' Rating on Cree, Inc. (CREE); Remains a Bright Spot in LEDs
-
Piper Jaffray Positive on Lincoln Electric (LECO) Shares After Meeting with Management
-
Biomass Producer PetroAlgae Files $200M IPO
-
Kanghui Holdings (KH) IPO Trades Higher
-
Kanghui Holdings (KH) IPO Prices at $10.25
-
Piper Jaffray Slashes Target on Mindray Medical (MR) to $34
-
Netflix (NFLX) Stikes Deal with Epix For Stearming Movie Content, Shares Roar Higher
-
Piper Jaffray Maintains an 'Overweight' Rating on Tower Group (TWGP); Underwriting Leads to In-Line Quarter, Guidance Reaffirmed
-
Piper Jaffray Maintains an 'Overweight' Rating on Gartner (IT); Boosting Estimates & Price Target on Strong 2Q Results
-
Piper Jaffray Boosts Target on Fossil (FOSL) to $58; Reiterates Overweight Amid Blow-Out Q2
-
American Public Education (APEI) Cut to Neutral at Piper Jaffray
-
Piper Jaffray Still Bullish on McDonald's (MCD) Following Strong July Comps
-
Daily State of the Market 8/6: A Big Disagreement?
-
Piper Jaffray Downgrades Beacon Roofing Supply (BECN) to Neutral; Timing Of Roofing Market Recovery Delayed
-
Piper Jaffray Downgrades Genzyme (GENZ) to Neutral on Valuation; Further Upside Dependent on M&A
-
Earnings Preview: Will Investors Kick CROCS (CROX) to the Curb Following Q2 Results? (AAPL, TBL, SKX, More...)
-
Gordmans Store (GMAN) IPO Trades Higher
-
Piper Jaffray Cuts Isis Pharma (ISIS) to Neutral
-
Piper Jaffray Cuts Optimer Pharma (OPTR) to Neutral
-
Piper Jaffray Lowers Target on Peet's (PEET) to $32; Reiterates Neutral Rating
-
Piper Jaffray Remains Bullish on Valeant Pharma (VRX) Following Q2 Beat
-
Piper Jaffray Restarts WuXi (WX) at Neutral as Charles River Deal Called Off
-
Piper Jaffray Reiterates Overweight on Finisar (FNSR) Ahead of Q1 Earnings
-
Glimcher Realty Trust (GRT) Completes 16.1M Common Offering at $6.25/Share; $96M Net Proceeds
-
Piper Jaffray Downgrades MWI Veterinary Supply (MWIV) to Neutral; Valuation Call
-
Chesapeake Midstream Partners, L.P (CHKM) IPO Trades Higher
-
Piper Jaffray Cuts Solera (SLH) to Neutral
-
China Kanghui Holdings (KH) Sees IPO Price of $9.25 - $11.25/ADS
-
Notable Analyst Rating Changes 07/28: DWA, CHRW, KFT, BP Upgraded; GFN, CEPH, WBSN, NE Downgraded
-
Piper Jaffray Cuts ARM Holdings (ARMH) to Neutral
-
Piper Jaffray Raises DreamWorks (DWA) to Overweight Following Q2 Results
-
FedEx (FDX) Guidance Raised On Strong Volume Growth, Shares Jump
-
Wall Street Aflutter With Genzyme (GENZ) Takeover Speculation
-
FBR Capital Broker/Dealers: Mid-Season Earnings Recap - Summary and Recommendation
-
Notable Analyst Rating Changes 07/23: NOK, BAX, MSFT, BIDU Upgraded; BEC, FLEX, QGLC, LPS, TRAD Downgraded
-
Verizon (VZ) Connects With Solid Q2 Results
-
Piper Jaffray Downgrades Beckman Coulter (BEC) to Neutral; Surprise! Beckman Reports Weak 2Q10
-
Gordmans Stores (GMAN) Sees IPO Price at $13 - $15/Share
-
Piper Jaffray Initiates Coverage on China New Borun (BORN) with an Oveweight; Corn Becomes Wine
-
Pebblebrook Hotel Trust (PEB) Prices 17M Common Offering at $17.00/Share
-
Genzyme (GENZ) Target Edged Higher to $73 at Piper Jaffray
-
Piper Jaffray Raises Price Target on F5 Networks (FFIV) to $83 But Stock Already Trading at This Level
